Absence of mutations in GJB 2 ( Connexin-26 ) gene in an ethnic group of southwest Iran

BACKGROUND: The common GJB2 gene mutation (35delG) has been previously reported from Iranian patients that were affected with nonsyndromic autosomal recessive deafness. We, therefore, for the first time, investigated the prevalence and frequency of the GJB2 gene mutation in the Iranian deaf population with Arabian origins. MATERIALS AND METHODs: We amplified and sequenced the entire coding sequence of the GJB2 gene from 61 deaf patients and 26 control subjects. RESULT: None of the analyzed samples revealed deafness-associated mutation. CONCLUSION: This finding differs from several reports from Iran as we have focused on the GJB2 gene that possesses various mutations as the cause of congenital recessive deafness.


Introduction
Congenital deafness is a common form of hearing impairment, which occurs in about one in 1000 live births. [1,2]The majority of the affected individuals are ascribed to unknown or presumed genetic factors.
Approximately 80% of the hereditary cases are nonsyndromic and are inherited in an autosomalrecessive mode. [3,4]To date, more than 40 loci have been mapped on human chromosomes that are thought to be linked with the Nonsyndromic Autosomal Recessive Deafness (NSARD), but most of these associated genes in their loci have not yet been identified.] Up to now, more than 35 different mutations have been described in the GJB2 gene and most of them are located in the coding region of connexin-26. [8]14] Furthermore, a specific T deletion at codon 167 (167delT) has also been identified in the GJB2 gene that appears mainly in Ashkenazi Jews. [7]erefore, to investigate the prevalence and frequency of the GJB2 gene mutation, we analyzed NSARD patients with Arabian origin.

Direct sequencing of the PCR products
The PCR products were purified by the PCR product extraction kit (Fermentase) and sequenced subsequently with the reverse primer and the Big-Dye Terminator

Results
In the present study, we have investigated a full spectrum of the GJB2 gene mutations in the Arabian

Discussion
This is the first report from Iran that shows the total absence of GJB2 gene mutation in a significant number of NSARD patients with Arabian origins despite GJB2 gene mutations, which have been described in several populations as well as in the Iran [19] [Figure 1].These mutations are 35delG, 167delT, and 235delC, which have been found to be very common in Caucasoid, Ashkenazi Jewish, and Oriental populations, respectively.
Carrier frequency of the 35delG mutation in the Caucasoid population occurs 1/31-1/35. [6,24,25]The carrier frequency of the 167delT mutation in the Ashkenazi Jews population is about 4% while the frequency of the 35delG mutation in the same population was reported to be 0.7%. [7]The mutation 235delC was detected in the Japanese population [12,26,27] as the main mutated allele in the deafness patients.The frequency of this mutation in the Japanese population has been determined to be 2/203 by Fuse et al. [26] In none of these studies was the 35delG mutation observed.Furthermore, the M34T mutation is also quite frequent in some populations.
The carrier frequency for this mutation in the Belgian population, as has been reported by Hilbert et al., was about 2.4%.Carrier screening for the M34T frequency in the Caucasoid populations, as established by Kelley et al. [28] and Scott et al., [29] was 3/192 and 1/200, respectively.
The most interesting finding in our study was the absence of any mutation associated with deafness, including the commonly described mutations 35delG, 427C>T(R143W), 167delT, and 235delC in the connexin-26 (GJB2) gene in an ethnic group of the Figure 1: GJB2 mutation passage through Iran [14] Iranian Arab NSARD patients.However, the average mutation rate in the GJB2 gene has been reported to be about 14.6% in the Iranian population [17,19,21] [Figure 1].
Similar to our finding, the absence of 35delG mutation has also been reported in the Omani population. [15] view of the fact that no GJB2 mutation was identified in our samples, we conclude that the GJB2 gene is not the major cause of NSARD at least in the Iranian population with Arabian origins.However, it may contribute, by some unknown interactions, with other genes.To date, linkage studies have indicated the presence of more than 40 different genes associated with NSARD.In addition, the Iranian population is composed of several ethnic groups and more work on the basis of the ethnicity is needed to find out which gene(s) is associated with NSARD.
Finally, we presumed that the direct methods to mutation detection could be more confident and those have been compared with other methods as well as the amplification refractory mutation system (ARMS) or the single-strand conformational polymorphism, which may be accompanied with false positive results, as we have had negative experience with the ARMS method (unpublished data) in our laboratory.
Individuals were ascertained through the genetic counseling center of the welfare organization of Ahwaz.Informed consent was obtained from all family members who participated in the study.Medical and family history and information on pedigree structure were obtained from 61 diagnosed persons with autosomal-recessive nonsyndromic hearing loss and 26 control subjects.Puretone audiometry at 2500-8000 Hz was performed for selected subjects.All hearing-impaired family members underwent physical examination.No clinical features, including mental retardation, which would indicate that deafness was part of a syndrome, were observed.
population from southwest Iran by direct sequencing of the PCR products.No GJB2 mutations, including the common 35delG, were found in the analyzed individuals from 61 NSARD patients and their 26 related healthy family members.Simply, one polymorphism (V153I) was detected in two related individuals in the heterozygote mode.

1
Department of Genetics, Faculty of Science, Chamran University, 2 Genetic Consulting Centre, Welfare Organization, Ahwaz, Iran at 72°C after the last cycle.The PCR products were then separated on a 1.5% agarose gel (Sigma Chemical Co., Poole, England) by electrophoresis to check for proper amplification with genomic DNA.